日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical and Clinical-Scale Magnetic Particle Imaging of Natural Killer Cells: in vitro and ex vivo Demonstration of Cellular Sensitivity, Resolution, and Quantification.

自然杀伤细胞的临床前和临床规模磁粒子成像:体外和离体细胞敏感性、分辨率和定量证明

Sehl Olivia C, Yang Yanwen, Anjier Ariana R, Nevozhay Dmitry, Cheng Donghang, Guo Kelvin, Fellows Benjamin, Mohtasebzadeh Abdul Rahman, Mason Erica E, Sanders Toby, Kim Petrina, Trease David, Koul Dimpy, Goodwill Patrick W, Sokolov Konstantin, Wintermark Max, Gordon Nancy, Greve Joan M, Gopalakrishnan Vidya

MGMT function determines the differential response of ATR inhibitors with DNA-damaging agents in glioma stem cells for GBM therapy

MGMT功能决定了胶质瘤干细胞中ATR抑制剂与DNA损伤剂在胶质瘤治疗中的差异性反应。

Leong, Vincent W S; Khan, Sabbir; Sharma, Pratibha; Wu, Shaofang; Thomas, Riya R; Li, Xiaolong; Singh, Sanjay K; Lang, Frederick F; Yung, Alfred W K; Koul, Dimpy

Pulsed focused ultrasound alters the proteomic profile of the tumor microenvironment in a syngeneic mouse model of glioblastoma.

脉冲聚焦超声改变了胶质母细胞瘤同源小鼠模型中肿瘤微环境的蛋白质组学特征

Chen Hui, Koul Dimpy, Zhang Yanrong, Ghobadi Sara Natasha, Zhu Yayu, Hou Qingyi, Chang Edwin, Habte Frezghi G, Paulmurugan Ramasamy, Khan Sabbir, Zheng Yuqi, Graeber Manuel B, Herschmann Iris, Lee Kevin S, Wintermark Max

Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation

对端粒酶活性的综合分析揭示了其与癌症干细胞特性和增殖之间的关联

Noureen, Nighat; Wu, Shaofang; Lv, Yingli; Yang, Juechen; Alfred Yung, W K; Gelfond, Jonathan; Wang, Xiaojing; Koul, Dimpy; Ludlow, Andrew; Zheng, Siyuan

The promise of DNA damage response inhibitors for the treatment of glioblastoma

DNA损伤反应抑制剂在胶质母细胞瘤治疗中的应用前景

Majd, Nazanin K; Yap, Timothy A; Koul, Dimpy; Balasubramaniyan, Veerakumar; Li, Xiaolong; Khan, Sabbir; Gandy, Katilin S; Yung, W K Alfred; de Groot, John F

Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells

撤稿:新型 HSP90 抑制剂 NVP-HSP990 靶向细胞周期调节因子以清除 Olig 2 阳性胶质瘤肿瘤起始细胞

Koul, Dimpy; Yao, Jun; Wan, Shuzhen; Yuan, Ying; Sulman, Erik; Lang, Frederick; Yung, W K Alfred; Colman, Howard

Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells

新型HSP90抑制剂NVP-HSP990靶向细胞周期调节因子,以清除Olig2阳性的胶质瘤肿瘤起始细胞。

Fu, Jun; Koul, Dimpy; Yao, Jun; Wang, Shuzhen; Yuan, Ying; Colman, Howard; Sulman, Erik P; Lang, Frederick F; Yung, W K Alfred

Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway

食管中结合型胆汁酸诱导MUC5AC黏蛋白的表达涉及磷脂酰肌醇3-激酶/蛋白激酶C/激活蛋白-1通路。

Song, Shumei; Byrd, James C; Guha, Sushovan; Liu, Kai-Feng; Koul, Dimpy; Bresalier, Robert S

Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma

双核铂化合物BBR3610与PI3-K抑制剂PX-866联合治疗胶质母细胞瘤

Gwak, Ho-Shin; Shingu, Takashi; Chumbalkar, Vaibhav; Hwang, Yeo-Hyeon; DeJournett, Robert; Latha, Khatri; Koul, Dimpy; Alfred Yung, W K; Powis, Garth; Farrell, Nicholas P; Bögler, Oliver

NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

NVP-BEZ235 是一种新型的双重磷脂酰肌醇 3-激酶/哺乳动物雷帕霉素靶蛋白抑制剂,对人类胶质瘤具有多方面的抗肿瘤活性。

Liu, Ta-Jen; Koul, Dimpy; LaFortune, Tiffany; Tiao, Ningyi; Shen, Rui Jun; Maira, Sauveur-Michel; Garcia-Echevrria, Carlos; Yung, W K Alfred